Nordic Veterinary Dermatology Drugs Market Size & Outlook, 2025-2033
Nordic Veterinary Dermatology Drugs Market Insights
- As highlighted in Reed Intelligence analysis, the Nordic Veterinary Dermatology Drugs Market, worth USD 109.85 Million in 2024, is forecasted to achieve USD 249.87 Million by 2033.
- The Nordic market is anticipated to grow at a CAGR of 9.61% during the period 2025–2033.
- By 2024, Non-steroidal anti-inflammatory drugs (NSAIDS) represented the largest share of the By Drug market size.
- Veterinary antifungal drug is expected to remain the key growth driver within By Drug, registering the fastest CAGR during the forecast period.
![Nordic Veterinary Dermatology Drugs Market Size, Share & Growth Analysis By [2033]](https://reedintelligence.com/uploads/charts/nordic-veterinary-dermatology-drugs-market-nordic-by-drug-42862.png)
Source: RI Analysis Company Publications, Primary Interviews.
Other Key Findings
- In 2024, Nordic represented 1.14% of the overall global Veterinary Dermatology Drugs Market size.
- United States is projected to lead the global Veterinary Dermatology Drugs Market size by 2033.
- Across Europe, Germany is anticipated to hold the dominant position in market size by 2033.
- Italy is forecasted to expand at the fastest pace in Europe, attaining USD 527.07 Million by 2033.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2033 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2033 |
| Market Size In 2024 | USD 109.85 Million |
| Market Size In 2033 | USD 249.87 Million |
| Largest segment | Non-steroidal anti-inflammatory drugs (NSAIDS) |
| Units | Revenue in USD Million |
| CAGR | 9.61% (2025-2033) |
| Segmnetation Covered | |
| By Drug |
|
| By Animal Type |
|
| By End Users |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
Nordic Veterinary Dermatology Drugs Market By Drug 2025-2033 (USD Million)
| By Drug | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-steroidal anti-inflammatory drugs (NSAIDS) | XX.x | XX.x | XX.x | 52.38 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Antibiotics | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Veterinary antifungal drug | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
Nordic Veterinary Dermatology Drugs Market By Animal Type 2025-2033 (USD Million)
| By Animal Type | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Large animals | XX.x | XX.x | XX.x | 70.58 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Small animals | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
Nordic Veterinary Dermatology Drugs Market By End Users 2025-2033 (USD Million)
| By End Users | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Veterinary Hospitals | XX.x | XX.x | XX.x | 63.28 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Veterinary Clinics | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
